|
VBP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.51729739883422E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.66089364483923E-13 |
| Normal-vs-Stage2 |
9.115900E-02 |
| Normal-vs-Stage3 |
7.888000E-02 |
| Normal-vs-Stage4 |
9.34380000039425E-07 |
| Stage1-vs-Stage2 |
2.089800E-01 |
| Stage1-vs-Stage3 |
1.506130E-02 |
| Stage1-vs-Stage4 |
9.530000E-01 |
| Stage2-vs-Stage3 |
6.704600E-01 |
| Stage2-vs-Stage4 |
2.627600E-01 |
| Stage3-vs-Stage4 |
4.232100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.51674245280265E-12 |
| Normal-vs-AfricanAmerican |
3.62339999999683E-05 |
| Normal-vs-Asian |
8.251400E-01 |
| Caucasian-vs-AfricanAmerican |
1.591170E-01 |
| Caucasian-vs-Asian |
4.026800E-01 |
| AfricanAmerican-vs-Asian |
5.467000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.66178182325893E-12 |
| Normal-vs-Female |
7.178400E-03 |
| Male-vs-Female |
8.60600000041067E-07 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.36619999979715E-07 |
| Normal-vs-Extreme_Weight |
1.8322010575389E-12 |
| Normal-vs-Obese |
5.88639999965501E-07 |
| Normal-vs-Extreme_Obese |
1.122190E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.554200E-02 |
| Normal_Weight-vs-Obese |
7.748400E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.237800E-01 |
| Extreme_Weight-vs-Obese |
4.064200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.277200E-01 |
| Obese-vs-Extreme_Obese |
6.414000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.653800E-01 |
| Normal-vs-Age(41-60Yrs) |
3.98450161753772E-11 |
| Normal-vs-Age(61-80Yrs) |
1.55739865448368E-11 |
| Normal-vs-Age(81-100Yrs) |
9.19200000004672E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.263030E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.187700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.001600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.628000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.433800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.830400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.24344978758018E-14 |
| Normal-VS-Type2 PRCC |
2.35709999999445E-05 |
| Normal-VS-KIRP CIMP |
4.044400E-01 |
| Normal-VS-Unclassified PRCC |
8.40909999966222E-07 |
| Type1 PRCC-VS-Type2 PRCC |
2.362500E-03 |
| Type1 PRCC-VS-KIRP CIMP |
2.679500E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
9.016000E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.687600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.809400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.626400E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.98000000004328E-06 |
| Normal-vs-N1 |
2.167700E-02 |
| Normal-vs-N2 |
6.641000E-04 |
| N0-vs-N1 |
1.683600E-01 |
| N0-vs-N2 |
7.829000E-01 |
| N1-vs-N2 |
2.823200E-01 |
|
|
